MIA launches IATA’s CEIV Programme
NOV 4, 2015: Miami International Airport, already a major hub for pharmaceutical imports and exports,became the first U.S. airport to partner with the International Air Transport Association’s global certification program for handling and shipping pharmaceutical products.
To avoid spoilage of sensitive pharmaceutical products and boost international trade, IATA, the international airline trade association representing about 260 air carriers, is providing assessment and training in cold-chain pharmaceutical transportation to certify participants in MIA’s air cargo supply chain, including air cargo carriers, logistics companies, truckers, freight forwarders and warehouses.
Many pharmaceutical products — such as temperature-sensitive drugs, vaccines and blood products — require precise temperature controls from the time they leave a manufacturing facility until the moment they reach their destinations at hospitals, laboratories and research centers in the U.S. and overseas.
The partnership bolsters a growing segment of MIA’s air cargo portfolio. The value of pharmaceutical imports and exports moving through MIA grew by 79 percent between 2010 and 2014, from about $1.8 billion in 2010 to nearly $3.3 billion in 2014, according to figures supplied by MIA. The figure does not include goods passing through the airport in-transit cargo.
MIA was the No. 1 U.S. airport last year in moving international air cargo, and No. 10 worldwide, handling 2.17 million tons of cargo in 2014 valued at $61.6 billion.
“MIA’s pharma freight hub certification by IATA brands the airport to pharmaceutical manufacturers as a trusted industry leader that transports their products in accordance with global best practices,” said Emilio T. González, director and CEO of Miami-Dade Aviation Department. “The designation also highlights our leadership as a safe and efficient logistics hub for these high-value, temperature-sensitive and often life-saving drugs and medicines. With MIA already ranked as the busiest airport in the country for international freight and perishable imports, this prestigious certification is expected to significantly increase the $3.3 billion in pharma traffic we already handle and position us among the top pharma markets in the U.S.”
According to Jason Sinclair, manager of IATA’s corporate communications for the Americas, “This IATA certification program speaks to its sophistication within the market here, and the sophistication of the companies that work with MIA.”
While MIA’s international pharma trade has grown, the global air cargo share of global pharmaceutical product transport declined from 17 percent to 13 percent between 2000 and 2013, according to IATA documents.
This occurred even as the global pharma market for temperature-management services was booming. The decrease was due mainly to a lack of standardization, compliance, accountability and transparency, the airline association said, that resulted in billions of dollars in annual losses. More than 50 percent of all temperature failures occur while pharma products are in the hands or airlines and airports.